David Vrána

2.2k total citations
67 papers, 1.3k citations indexed

About

David Vrána is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David Vrána has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in David Vrána's work include Breast Cancer Treatment Studies (9 papers), Esophageal Cancer Research and Treatment (8 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). David Vrána is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Esophageal Cancer Research and Treatment (8 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). David Vrána collaborates with scholars based in Czechia, Japan and United Kingdom. David Vrána's co-authors include Bohuslav Melichar, Pavel Souček, Michal Holčapek, Jiří Gatěk, Eva Cífková, Veronika Brynychová, Miroslav Lísa, Viktor Hlaváč, Robert Jirásko and Č Neoral and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

David Vrána

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Vrána Czechia 20 666 368 364 191 160 67 1.3k
Gerda Hofstetter Austria 23 608 0.9× 595 1.6× 344 0.9× 147 0.8× 256 1.6× 56 1.7k
Hui‐Ming Lin China 22 638 1.0× 463 1.3× 371 1.0× 307 1.6× 257 1.6× 97 1.5k
Xinchun Zhou United States 22 1.1k 1.7× 243 0.7× 517 1.4× 216 1.1× 188 1.2× 62 1.9k
Mingming Deng China 18 417 0.6× 158 0.4× 210 0.6× 218 1.1× 111 0.7× 87 986
Tetsuya Okano Japan 27 1.2k 1.9× 832 2.3× 596 1.6× 515 2.7× 133 0.8× 96 2.5k
R Barrios United States 11 690 1.0× 297 0.8× 297 0.8× 649 3.4× 78 0.5× 17 1.6k
Zhiqian Hu China 22 675 1.0× 521 1.4× 330 0.9× 294 1.5× 505 3.2× 77 1.6k
Zitong Zhao China 21 580 0.9× 170 0.5× 313 0.9× 109 0.6× 109 0.7× 55 1.0k
Kiyoshi Koshida Japan 19 502 0.8× 218 0.6× 183 0.5× 399 2.1× 219 1.4× 80 1.2k

Countries citing papers authored by David Vrána

Since Specialization
Citations

This map shows the geographic impact of David Vrána's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vrána with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vrána more than expected).

Fields of papers citing papers by David Vrána

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vrána. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vrána. The network helps show where David Vrána may publish in the future.

Co-authorship network of co-authors of David Vrána

This figure shows the co-authorship network connecting the top 25 collaborators of David Vrána. A scholar is included among the top collaborators of David Vrána based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vrána. David Vrána is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holý, Petr, Veronika Brynychová, Markéta Trnková, et al.. (2023). Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early‐stage luminal breast cancer. Molecular Oncology. 17(10). 2074–2089. 6 indexed citations
2.
Hlaváč, Viktor, Radka Václavíková, Veronika Brynychová, et al.. (2021). Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response. International Journal of Molecular Sciences. 22(6). 2826–2826. 10 indexed citations
3.
Hlaváč, Viktor, Radka Václavíková, Veronika Brynychová, et al.. (2020). Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response. International Journal of Molecular Sciences. 21(24). 9556–9556. 22 indexed citations
4.
Peterka, Ondřej, Robert Jirásko, Michaela Chocholoušková, et al.. (2020). Lipidomic characterization of exosomes isolated from human plasma using various mass spectrometry techniques. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(5). 158634–158634. 47 indexed citations
5.
Vrána, David, Viktor Hlaváč, Radka Václavíková, et al.. (2018). ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. International Journal of Molecular Sciences. 19(3). 868–868. 25 indexed citations
6.
Hlaváč, Viktor, Veronika Brynychová, Kateřina Kopečková, et al.. (2018). Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients. Cancers. 10(12). 511–511. 16 indexed citations
7.
Vrána, David, Č Neoral, R Aujeský, et al.. (2018). From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer. International Journal of Molecular Sciences. 20(1). 13–13. 113 indexed citations
8.
Vrba, Radek, David Vrána, Č Neoral, et al.. (2018). Respiratory complications following mini-invasive laparoscopic and thoracoscopic esophagectomy for esophageal cancer. Experience in 215 patients.. Videosurgery and Other Miniinvasive Techniques. 14(1). 52–59. 5 indexed citations
9.
Melichar, Bohuslav, David Vrána, Tomáš Adam, et al.. (2017). Neoadjuvant combination therapy with trastuzumab in a breast cancer patient with synchronous rectal carcinoma: a case report and biomarker study. Pteridines. 28(3-4). 233–241. 1 indexed citations
10.
Vrána, David, et al.. (2017). Stereotactic radiotherapy in the treatment of local recurrences of esophageal cancer. Oncology Letters. 13(3). 1807–1810. 4 indexed citations
11.
Adam, Tomáš, Lenka Kujovská Krčmová, Dagmar Solichová, et al.. (2016). Prognostic Significance of Serum and Urinary Neopterin Concentrations in Patients with Rectal Carcinoma Treated with Chemoradiation.. PubMed. 36(1). 287–92. 7 indexed citations
12.
Brynychová, Veronika, Radka Václavíková, Kateřina Kubáčková, et al.. (2016). Clinical and Functional Importance of Selected CASP8 and CASP9 Polymorphisms in Breast Carcinoma. Klinicka onkologie. 29(6). 445–453. 3 indexed citations
13.
14.
Hlaváč, Viktor, Veronika Brynychová, Radka Václavíková, et al.. (2014). The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients. Medicine. 93(28). e255–e255. 24 indexed citations
15.
Kunická, Tereza, Radka Václavíková, Viktor Hlaváč, et al.. (2014). Non-Coding Polymorphisms in Nucleotide Binding Domain 1 in ABCC1 Gene Associate with Transcript Level and Survival of Patients with Breast Cancer. PLoS ONE. 9(7). e101740–e101740. 16 indexed citations
16.
Vrána, David, Jiří Gatěk, Pavel Koranda, et al.. (2014). Predictive parameters for internal mammary node drainage in patients with early breast cancer.. PubMed. 100(3). 254–8. 7 indexed citations
17.
Melichar, Bohuslav, Hana Študentová, Hana Kalábová, et al.. (2013). Systemic immune response and peripheral blood cell count in patients with a history of breast cancer. Pteridines. 24(3-4). 211–217. 3 indexed citations
18.
Gatěk, Jiří, et al.. (2013). Significance of resection margin as a risk factor for local control of early stage breast cancer. Biomedical Papers. 157(3). 209–213. 4 indexed citations
19.
Melichar, Bohuslav, Hana Študentová, Hana Kalábová, et al.. (2013). Risk factors of atherosclerosis in patients with history of breast cancer. Pteridines. 24(3-4). 201–210. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerda Hofstetter Breakdown of academic impact, for papers by Hui‐Ming Lin Breakdown of academic impact, for papers by Xinchun Zhou Breakdown of academic impact, for papers by Mingming Deng Breakdown of academic impact, for papers by Tetsuya Okano Breakdown of academic impact, for papers by R Barrios Breakdown of academic impact, for papers by Zhiqian Hu Breakdown of academic impact, for papers by Zitong Zhao Breakdown of academic impact, for papers by Kiyoshi Koshida
Rankless by CCL
2026